APA (7th ed.) Citation

QA, W., HW, C., RC, W., & CE, W. (2023). Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor. Current treatment options in oncology, 24(12), 1683. https://doi.org/10.1007/s11864-023-01144-6

Chicago Style (17th ed.) Citation

QA, Wang, Chen HW, Wu RC, and Wu CE. "Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor." Current Treatment Options in Oncology 24, no. 12 (2023): 1683. https://doi.org/10.1007/s11864-023-01144-6.

MLA (9th ed.) Citation

QA, Wang, et al. "Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor." Current Treatment Options in Oncology, vol. 24, no. 12, 2023, p. 1683, https://doi.org/10.1007/s11864-023-01144-6.